Literature DB >> 544584

Prophylactic ibuprofen administration during pelvic irradiation.

J A Stryker, L M Demers, R Mortel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 544584     DOI: 10.1016/0360-3016(79)90958-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  6 in total

Review 1.  Pharmacological Agents Affecting Emesis : A Review (Part II).

Authors:  F Mitchelson
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

Review 2.  A systematic review of methodologies, endpoints, and outcome measures in randomized trials of radiation therapy-induced nausea and vomiting.

Authors:  Kristopher Dennis; Rehana Jamani; Clare McGrath; Leila Makhani; Henry Lam; Patrick Bauer; Carlo De Angelis; Natalie Coburn; C Shun Wong; Edward Chow
Journal:  Support Care Cancer       Date:  2017-03-31       Impact factor: 3.603

3.  High-dose dexamethasone for prevention of cis-platin-induced vomiting.

Authors:  M S Aapro; D S Alberts
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

Review 4.  Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers.

Authors:  Theresa A Lawrie; John T Green; Mark Beresford; Linda Wedlake; Sorrel Burden; Susan E Davidson; Simon Lal; Caroline C Henson; H Jervoise N Andreyev
Journal:  Cochrane Database Syst Rev       Date:  2018-01-23

5.  Dexamethasone can potentiate the anti-emetic action of a 5HT3 receptor antagonist on cyclophosphamide induced vomiting in the ferret.

Authors:  J Hawthorn; D Cunningham
Journal:  Br J Cancer       Date:  1990-01       Impact factor: 7.640

6.  Effect of the new synthetic vitamin E derivative ETS-GS on radiation enterocolitis symptoms in a rat model.

Authors:  Satoshi Sugita; Masafumi Inomata; Yohei Kono; Hidefumi Shiroshita; Tsuyoshi Etoh; Norio Shiraishi; Seigo Kitano
Journal:  Oncol Lett       Date:  2013-09-12       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.